Nektar Therapeutics (Nasdaq: NKTR) today announced new data from the ongoing REZOLVE-AD Phase 2b study of rezpegaldesleukin, ...

Constant loss of smell, facial pain and a blocked nose are a reality for the 10 per cent of people living with chronic ...

Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at week 24, ...

Eli Lilly and Company LLY has gained tremendous market value in the past 2-3 years due to the success of its popular GLP-1 ...

Exercising with eczema needs care. Sweat, friction, and heat can trigger flare-ups. Opt for breathable fabrics, short ...

July 24, 2025 – The FDA has approved a new treatment as the first and only skin cream for a specific type of hand eczema that affects about 1 in every 10 people globally. The cream, sold under the ...

This year a clinical trial will test a drug combination designed to bring lasting relief for people with panic disorder – a condition that can upend daily life and be notoriously difficult to treat.

Featured presentations showcase the positive Phase 1 healthy volunteer trial results supporting KT-621’s oral, dupilumab-like profileKT-621 ...

Stress during pregnancy, perhaps around the 6-to-8-month mark especially, may prime certain immune cells in a fetus’s skin to overreact, leading to eczema. Immune cells called mast cells in the skin ...

ZORYVE is the number one prescribed branded topical therapy across three major inflammatory dermatoses combined—eczema, ...